At the news
? BEARISHIMPACT 6/10 6-K filed Aug 14, 2026 at 07:02 ET
Smith+Nephew reported H1 2026 revenue of $3,097M (+4.6% reported, +2.3% underlying) and trading profit of $566M (+8.1%), but cut full-year underlying revenue growth guidance from ~6% to ~4%, citing softness in US Orthopaedics and Advanced Wound Bioactives. While trading profit, free cash flow, and ROIC guidance were maintained via cost cuts, the revenue guidance reduction is a material negative signal that overshadows the profit beat.
- H1 2026 revenue was $3,097M, up 4.6% reported / 2.3% underlying vs H1 2025.
- Full-year underlying revenue growth guidance cut from ~6% to ~4%.
- H1 trading profit was $566M, up 8.1% vs H1 2025; trading profit margin up 60bps to 18.3%.
- Q2 2026 revenue was $1,597M, with underlying growth of just 1.6%.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access